AbbVie Inc (MEX:ABBV)
MXN 3585.03 38.93 (1.1%) Market Cap: 6.16 Tn Enterprise Value: 7.46 Tn PE Ratio: 61.23 PB Ratio: 51.65 GF Score: 75/100

Abbvie Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 05:35PM GMT
Release Date Price: MXN2902.51 (+2.56%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

My pleasure to welcome AbbVie to the stage. No shortage of debates and controversies and launches going on. So thank you, AbbVie, for joining. Joining us from the company, Robert Michael, Vice Chairman and President; Scott Reents, CFO; Jeff Stewart, Chief Commercial Officer; as well as Roopal Thakkar, Development and Regulatory Affairs and CML.

Thank you Rob and team.

Rob Michael
Abbvie Inc - Vice Chairman and President

Thanks for having us.

Questions & Answers

Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Great. So we're going to just jump right into Q&A. Aesthetics has been sort of top of mind for many folks. And so I thought we'd start there. I think the company flagged uncertainty around some of the trends in the space, dating back to last year and certainly at the 4Q call. You've also referenced some stabilization in those metrics. So I guess the question is sort of what are you seeing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot